Clinical-stage biopharmaceutical company
Appears in 1 story · Last updated Oct 25, 2026
Planning FDA resubmission for bitopertin
People with erythropoietic protoporphyria feel stabbing pain in strong light, and no oral drug is approved to help them. Disc Medicine's bitopertin passed a 183-patient Phase 3 trial called APOLLO, the company said on Oct. 19, 2026, reopening a path to the FDA after a rejection in February.
Updated Oct 25
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
